🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
To explore the efficacy and safety of vebreltinib plus platinum-doublet che...
Status
Not Yet Recruiting
Location
241 West Huaihai Road, Xuhui District, Shanghai, 200030, China.
Start Date
2026-03-30
Trial ID
NCT07549061
Treatments Being Tested
The purpose of this prospective study is to perform Nerve conduction test, ...
Status
Unknown
Location
Himalayan Hospital(Cancer Research Institute), Himalayan Institute of Medical Sciences
Start Date
2022-11-23
Trial ID
NCT06491082
Treatments Being Tested
The combination of pEBV DNA (half-life) and PET-CT following 1 course of ch...
Status
Completed
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2011-07
Trial ID
NCT01365208
Treatments Being Tested
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
The primary purpose of this study is to help answer the following research ...
Status
Completed
Location
Highlands Oncology Group
Start Date
2010-04
Trial ID
NCT01099358
Treatments Being Tested